Veröffentlichungen

Seliger, C., Schaertl, J., Gerken, M., Luber, C., Proescholdt, M., Riemenschneider, M.J., Leitzmann, M.F., Hau, P., Klinkhammer-Schalke, M., 2018. Use of statins or NSAIDs and survival of patients with high-grade glioma. PLoS One 13, e0207858

Voelkel, V., Draeger, T., Gerken, M., Fuerst, A., Klinkhammer-Schalke, M., 2018a. Colorectal Cancer Centers in Germany: Does certification yield to a survival benefit? Oncol. Res. Treat. 41, 57–57.

Voelkel, Vinzenz, Draeger, T., Gerken, M., Klinkhammer-Schalke, M., Fuerst, A., 2018. Long-term oncologic outcomes after laparoscopic vs. open colon cancer resection: a high-quality population-based analysis in a Southern German district. Surg. Endosc. 32, 4138–4147.

Voelkel, V., Draeger, T., Gerken, M., Klinkhammer-Schalke, M., Fuerst, A., 2018b. Oncological long-term outcomes after laparoscopic vs. open colon cancer resection: A high-quality population-based analysis in a southern German district. Oncol. Res. Treat. 41, 56–57.

Wege, A.K., Chittka, D., Buchholz, S., Klinkhammer-Schalke, M., Diermeier-Daucher, S., Zeman, F., Ortmann, O., Brockhoff, G., 2018. HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women. Breast Cancer Res. 20, 139.

Munker, S., Gerken, M., Fest, P., Ott, C., Schnoy, E., Fichtner-Feigl, S., Wiggermann, P., Vogelhuber, M., Herr, W., Stroszczynski, C., Schlitt, H.J., Evert, M., Reng, M., Klinkhammer-Schalke, M., Teufel, A., 2018. Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects. BMC Cancer 18, 455.

Ortmann, O., Helbig, U., Torode, J., Schreck, S., Karjalainen, S., Bettio, M., Ringborg, U., Klinkhammer-Schalke, M., Bray, F., 2018. Quality control and improvement of cancer care: what is needed? 4th European Roundtable Meeting (ERTM) May 5th, 2017, Berlin, Germany. J. Cancer Res. Clin. Oncol. 144, 1097–1102.

Ott, C., Gerken, M., Hirsch, D., Fest, P., Fichtner-Feigl, S., Munker, S., Schnoy, E., Stroszczynski, C., Vogelhuber, M., Herr, W., Evert, M., Reng, M., Schlitt, H.J., Klinkhammer-Schalke, M., Teufel, A., 2018. Advanced Mucinous Colorectal Cancer: Epidemiology, Prognosis and Efficacy of Chemotherapeutic Treatment. Digestion 98, 143–152.

Papathemelis, T., Hassas, D., Gerken, M., Klinkhammer-Schalke, M., Scharl, A., Lux, M.P., Beckmann, M.W., Scharl, S., 2018a. Is there a benefit of lymphadenectomy for overall and recurrence-free survival in type I FIGO IB G1-2 endometrial carcinoma? A retrospective population-based cohort analysis. J. Cancer Res. Clin. Oncol. 144, 2019–2027.

Papathemelis, T., Jablonski, E., Scharl, A., Hauzenberger, T., Gerken, M., Klinkhammer-Schalke, M., Hipp, M., Scharl, S., 2018b. Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera. Biomed Res. Int. 2018, 6251468.

Piso, P., Stierstorfer, K., Gerken, M., Klinkhammer-Schalke, M., 2018. Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer. Int. J. Colorectal Dis. 33, 1559–1567.

Reinert, C., Rathberger, K., Klinkhammer-Schalke, M., Koelbl, O., Proescholdt, M., Riemenschneider, M.J., Schuierer, G., Hutterer, M., Gerken, M., Hau, P., 2018. Information needs and requirements in patients with brain tumours and their relatives. J. Neuro-Oncol. 138, 407–415.

Reiter, M., Gerken, M., Eberl, I., Bartholomeyczik, S., 2018. The Optimized Health Care Management of Patients with colorectal Cancer – A descriptive Study on Nursing Care Research. Oncol. Res. Treat. 41, 135–135.

Scharl, S., Papathemelis, T., Kronberger, K., Gerken, M., Scharl, A., Koelbl, O., Klinkhammer-Schalke, M., 2018. Does post-operative radiochemotherapy improve survival in high-grade endometrial cancer patients? Results of a population-based cohort analysis of a cancer registry. Arch. Gynecol. Obstet. 297, 1245–1253.

Seitz, S., Brockhoff, G., Weber, F., Klinkhammer-Schalke, M., Zeman, F., Ugocsai, P., Ortmann, O., Wege, A., 2018. The prognostic value of PD-L1/PD-1 expression and PD-L1 gene copy number on/in tumor and immune cells in triple negative breast cancer. Oncol. Res. Treat. 41, 4–4.

Draeger, T., Voelkel, V., Gerken, M., Klinkhammer-Schalke, M., Fuerst, A., 2018. Laparoscopic vs. open rectal cancer resection: Oncological long-term outcomes of a high-quality population-based analysis in a southern German district. Oncol. Res. Treat. 41, 57–57.

Draeger, Teresa, Voelkel, V., Gerken, M., Klinkhammer-Schalke, M., Fuerst, A., 2018. Long-term oncologic outcomes after laparoscopic versus open rectal cancer resection: a high-quality population-based analysis in a Southern German district. Surg. Endosc. 32, 4096–4104.

Haj, A., Doenitz, C., Schebesch, K.-M., Ehrensberger, D., Hau, P., Putnik, K., Riemenschneider, M.J., Wendl, C., Gerken, M., Pukrop, T., Brawanski, A., Proescholdt, M.A., 2018. Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center. Brain Sci. 8, 5.

Hofmann, H.-S., Braess, J., Leipelt, S., Allgaeuer, M., Klinkhammer-Schalke, M., Szoeke, T., Grosser, C., Pfeifer, M., Ried, M., 2018. Multimodality therapy in subclassified stage IIIA-N2 non-small cell lung cancer patients according to the Robinson classification: heterogeneity and management. J. Thorac. Dis. 10, 3585–3594.

Inwald, E., Klinkhammer-Schalke, M., Koller, M., Zeman, F., Ortmann, O., 2018. Screening-relevant age treshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Oncol. Res. Treat. 41, 1–2.

Klinkhammer-Schalke, M., Steinger, B., Koller, M., Furst, A., Piso, P., Kastel, M., Gumpp, J., Obermaier, R., Hofstaedter, F., Lindberg, P., 2018. Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomized trial including 220 patients with colorectal cancer. J. Clin. Oncol. 36.

Liebig-Hoerl, G., Puchner, C., Gerken, M., Klinkhammer-Schalke, M., Fuerst, A., 2018. Treatment strategy for early stage rectal cancer (T1 carcinoma). Chirurg 89, 358–364.